Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
CDXS Transcript
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Positive5-8
The earnings call highlights strong financial performance with a 12% revenue increase and improved gross margin and net income. Despite risks, management's optimistic 2026 guidance and milestone expectations suggest confidence in future growth. The absence of negative sentiment in the Q&A supports a positive outlook, likely leading to a 2-8% stock price increase.
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Positive3-11
The earnings call reflects positive sentiment due to improved financial performance, cost management, and optimistic guidance. The company reported a significant net income improvement, reduced expenses, and a strong cash position. Additionally, the strategic shift towards ECO Synthesis and promising collaborations suggest future growth. Despite some speculative elements in revenue guidance, the overall outlook is positive with anticipated revenue growth and strategic partnerships.
Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript
Unknown11-7
The earnings call reveals several concerns: a significant revenue decline, increased R&D expenses, and dependence on a single agreement for financial stability. Despite improved gross margins and a slight reduction in net loss, the transition risks, potential revenue drop, and economic uncertainties weigh heavily. The Q&A session offered no new positive insights and highlighted challenges, such as siRNA revenue not offsetting legacy declines. Given these factors, the stock is likely to experience a negative reaction, potentially in the range of -2% to -8%.
Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript
Positive8-13
The earnings call highlights several positive aspects: improved product gross margins, reduced net loss, and a solid cash position. The Q&A session indicates a growing pipeline and strategic focus on high-value opportunities. However, management's vague responses on capacity expansion and revenue growth create some uncertainty. Despite this, the overall sentiment is positive due to strong financial performance and strategic initiatives. The absence of negative catalysts like revenue misses or new secondary offerings further supports a positive outlook.
CDXS Slides
CDXS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
